HTG Molecular Diagnostics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
TUCSON, Ariz., July 23, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose...
News
AnPac Bio Announces Appointment of New Independent Director
Independent Director has Strong Track Record at US Fortune 500 CompaniesPHILADELPHIA, July 23, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science...
Abeona Therapeutics Activates Second Clinical Trial Site in EB-101 Pivotal Phase 3 VIITAL™ Study for Recessive Dystrophic Epidermolysis Bullosa
NEW YORK and CLEVELAND, July 23, 2021 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene...
Sigilon Therapeutics Presents Preclinical Data at the 16th International Symposium on MPS and Related Diseases
Company selected for oral presentation on mucopolysaccharidosis-1 (MPS-1), demonstrating potential of SIG-005 to provide sustained production of active human alpha-L-iduronidase...
Stabilizing Actions and End of Stabilization Period in connection with the Global Offering
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., July 23, 2021 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED” or...
Trevena Announces Two Leading Independent Proxy Advisory Firms Recommend Shareholders Vote “For” All Proposals Ahead of Special Meeting of Stockholders
Glass Lewis and Institutional Shareholder Services (ISS) independently recommend that Trevena shareholders vote “FOR” proposals to approve a Reverse Stock...
Pfizer And BioNTech to Supply U.S. Government with an Additional 200 Million Doses of COVID-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S.
Dose deliveries for new order expected to occur from October 2021 through April 2022NEW YORK AND MAINZ, GERMANY, July 23,...
Kirkwood MO Dental Crown Repair/Cap Fitting Restorative Dentistry Service Launch
Comprehensive dental practice, Geyer Dental Group (+1-314-965-4064) based in Kirkwood, MO, has launched updates to their dental crowns and restorative...
AzurRx BioPharma Increases Previously Announced Bought Deal to $5.0 Million
BOCA RATON, Fla., July 22, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical...
Sight Sciences Announces Multiple Presentations at the 2021 American Society of Cataract and Refractive Surgery Annual Meeting
New safety and efficacy data from both retrospective and prospective studies of the OMNI Surgical System and a prospective study...
SOPHiA GENETICS Announces Pricing of Initial Public Offering
BOSTON and LAUSANNE, Switzerland, July 22, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA, the creator of a global data pooling...
Genocea to Host Second Quarter 2021 Corporate Update Conference Call & Webcast
CAMBRIDGE, Mass., July 22, 2021 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation cancer immunotherapies,...
Chembio Diagnostics to Report Second Quarter 2021 Financial Results on August 5, 2021
HAUPPAUGE, N.Y., July 22, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on...
PSI Acquires ProSphere to Enhance its Position as a Health IT Leader
ARLINGTON, Va., July 22, 2021 (GLOBE NEWSWIRE) -- Planned Systems International, Inc. (PSI) announced today that it has acquired ProSphere...
Intrommune Therapeutics Presents at Next Generation Food Allergy Drug Summit
Scientific Data Outlines the Role of the Oral Mucosa in the Delivery of Peanut Allergy ImmunotherapyNEW YORK, July 22, 2021...
AzurRx BioPharma Announces $3.0 Million Bought Deal Offering of Common Stock
BOCA RATON, Fla., July 22, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical...
Supernus to Host Second Quarter 2021 Financial Results Conference Call
ROCKVILLE, Md., July 22, 2021 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and...
PLx Pharma Inc. to Discuss 2021 Second Quarter Financial Results on August 6, 2021 Conference Call and Provide Business Update
SPARTA, N.J., July 22, 2021 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a specialty pharmaceutical...
Travere Therapeutics to Report Second Quarter 2021 Financial Results
SAN DIEGO, July 22, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report second quarter...
Profound Medical to Participate in A.G.P.’s Virtual MedTech Summer Conference
TORONTO, July 22, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device...